F13.129
Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.129 refers to a condition where an individual abuses sedative, hypnotic, or anxiolytic medications, leading to intoxication. These medications are typically prescribed to help manage anxiety, sleep disorders, or certain medical conditions. However, misuse or excessive consumption can result in intoxication, which may impair mental and physical functions. Recognizing this condition is essential for providing appropriate treatment and support.
Causes & Symptoms
Clinical Causes: Attempting to self-medicate for stress, anxiety, or sleep problems without medical guidance Ongoing dependence on prescribed medications due to tolerance or psychological attachment Recreational use for their sedative or calming effects Co-occurring substance abuse behaviors involving alcohol or other drugs Mental health disorders like anxiety or depression that lead to misuse of medications
Key Symptoms: Drowsiness or sedation Confusion or disorientation Impaired coordination or balance Slurred speech Impairment in judgment and decision-making Respiratory depression in severe cases Altered mental state or decreased alertness Potential agitation or aggression upon withdrawal
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a clinical assessment by a healthcare professional, which includes reviewing medical history, medication use, and patterns of behavior. Laboratory tests such as blood or urine screenings can detect the presence of sedative or hypnotic substances. Healthcare providers may also evaluate for signs of intoxication and assess the severity of the abuse to determine appropriate intervention strategies.
Treatment Protocols: Treatment for sedative, hypnotic, or anxiolytic abuse with intoxication typically involves a combination of approaches tailored to the individual's needs. These may include: - Medical stabilization in cases of severe intoxication or overdose, which may require emergency care or hospitalization - Detoxification programs to safely manage withdrawal symptoms - Psychotherapy, including cognitive-behavioral therapy (CBT), to address underlying causes of substance abuse - Medication-assisted treatment where appropriate, possibly for co-occurring mental health issues - Support groups and counseling to promote recovery and prevent relapse - Development of a comprehensive relapse prevention plan, including medication management and behavioral strategies
Clinical Advice & FAQs
Billing Guidance
Is F13.129 a billable ICD-10 code?
Yes, F13.129 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.129?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference